Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype Response to: Nagy PL, Mansukhani M. The role of clinical genomic testing in diagnosis and discovery of pathogenic mutations. Expert Rev Mol Diagn 2015;15(9):1101-5

Expert Rev Mol Diagn. 2016 Jul;16(7):715-7. doi: 10.1080/14737159.2016.1184573. Epub 2016 May 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / genetics
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genomics
  • Genotype*
  • Germ-Line Mutation
  • Humans
  • Mutation*
  • Ovarian Neoplasms / genetics
  • Patient Care Team